Scout Investments, Inc. Vertex Pharmaceuticals Inc Transaction History

Scout Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $9,063 - $10,339	-32 Reduced 0.06%	57,963 $18.3 Million
Q4 2022 Jan 23, 2023	SELL	$285.76 - $321.48 $16.2 Million - $18.2 Million	-56,701 Reduced 49.44%	57,995 $0
Q3 2022 Oct 18, 2022	SELL	$273.83 - $305.53 $42.6 Million - $47.5 Million	-155,620 Reduced 57.57%	114,696 $33.2 Million
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $50,986 - $63,483	-217 Reduced 0.08%	270,316 $76.2 Million
Q1 2022 Apr 14, 2022	BUY	$221.42 - $260.97 $2.61 Million - $3.07 Million	11,775 Added 4.55%	270,533 $70.6 Million
Q4 2021 Jan 14, 2022	BUY	$177.01 - $223.45 $2.19 Million - $2.77 Million	12,385 Added 5.03%	258,758 $56.8 Million
Q3 2021 Oct 13, 2021	BUY	$181.39 - $202.99 $15 Million - $16.8 Million	82,519 Added 50.36%	246,373 $44.7 Million
Q2 2021 Jul 23, 2021	BUY	$187.49 - $221.1 $30.7 Million - $36.2 Million	163,854 New	163,854 $33 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.